mortality/aging
• succumb more rapidly following infection with Listeria monocytogenes compared to wild-type controls
• die following infection with Listeria monocytogenes doses that are non-lethal in wild-type controls
|
• prolonged survival following LPS and D-galactosamine treatment
|
immune system
• B cells stimulated with the nucleotide analog 2' (3')-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate (BzATP) show inhibited CD62L shedding
|
• following stimulation with LPS or LPS and D-galactosamine
|
• in culture LPS stimulated thioglycollate-elicited peritoneal macrophages shed less TNF into the media despite showing similar levels of mRNA upregulation and have increased levels of membrane bound protein
|
• higher bacterial loads in the spleen, liver, kidney, and brain following infection with Listeria monocytogenes compared to wild-type controls
|
• succumb more rapidly following infection with Listeria monocytogenes compared to wild-type controls
• die following infection with Listeria monocytogenes doses that are non-lethal in wild-type controls
|
• prolonged survival following LPS and D-galactosamine treatment
|
liver/biliary system
• decrease in amount of liver damage induced by LPS and D-galactosamine treatment
|
homeostasis/metabolism
• following stimulation with LPS or LPS and D-galactosamine
|
hematopoietic system
• B cells stimulated with the nucleotide analog 2' (3')-O-(4-benzoyl)benzoyl adenosine 5'-triphosphate (BzATP) show inhibited CD62L shedding
|